The health of mankind Prepare for a happy tomorrow.
Introducing our core competencies.
Introducing products and services.
HOME > Core competence > R&D
Superb research and development personnel
Professional advisory groups composed of
domestic and foreign experts
Overcoming the shortcomings of the protein production process,
Develop core technologies that can dramatically improve productivity
by simplifying complex muilt-step processes
Development of safest and most productive technology for human
milk oligosaccharide by using Corynebacterium glutamicum as a host
instead of E.coli
19 domestic patents and 24 international patents
Production and new use patents for
breat milk osaccharide
manufacturing compound protein patent
(Korea, China, Japan, Europe)Securing the Mamstamine brand
| Type | Location | Application/Approval | Number |
|---|---|---|---|
| Patent | Korea | Application | 9 |
| Approval | 12 | ||
| Overseas | Application | 12 | |
| Approval | 9 | ||
| Trademark | Korea | Application | 9 |
| Approval | 10 | ||
| Overseas | Application | 0 | |
| Approval | 5 |
| R&D Task & Dateils | Development Period | Business Scale | Remarks |
|---|---|---|---|
| Delvelopment of manufacturing process of nano disk membrane stuctured protein | 2007.06 ~ 2009.05 | KRW 200,000,000 | Completion |
| Delvelopment of commercialization technology of monoclonal antibody affinity ligand |
2007.10 ~ 2009.09 | KRW 433,300,000 | Completion (Chosen as comapany with outstranding performance) |
| commercialization of Herceptin Biosimilars |
2009.07 ~ 2010.06 | KRW 9,322,000,000 | Completion |
| Developed thrombocytopenic oral protein therapeutics using TPO Variants (Host organization) |
2010.06 ~ 2013.12 | KRW 840,000,000 | Completion |
| Bioproduction of long-chain dicarboxylic acids form fatty acides and lipids |
2013.06 ~ 2018.05 | KRW 4,332,000,000 | Completion |
| Delvelopment of high density lipoprotein like nanoparitcle of Epothilone B |
2013.06 ~ 2015.05 | KRW 830,000,000 | Completion |
| Bio-based production of isobutylene | 2014.06 ~ 2019.05 | KRW 5,166,665,000 | Completion |
| Process Delvelopment for Modified Entolimod |
2014.06 ~ 2019.05 | KRW 8,000,000,000 | Completion |
| Development of Fucosyllactose for Infant Formula |
2017.04 ~ 2019.12 | KRW 2,125,192,000 | Completion |
| Biological production of D-ribose and its application to foods development |
2018.09 ~ 2022.05 | KRW 2,529,952,000 | In Progress |
| Patent name | Applicant | Application/ Registration |
Date of resistration | Registration number |
|---|---|---|---|---|
| Production method of 2'-fucosyl lactose using fucose transferase derived form pseudofedobacter saltans |
AP Technologies | Approved | 2015 -08-06 |
10154 4184 |
| Cosmetic composition for skin irritation alleviation with 2'-fucosyllactose | AP Technologies | Approved | 2017 -04-24 |
10173 1263 |
| Method for increase stability, survival rate, acid resistance, bile resistance of lactic acid bacteria width 2'-FL or 3'-FL, human milk oligosaccharide |
AP Technologies | Filed | 2019 -11-25 |
10205 0522 |
| Method for production of lactic acid bacteria with human milk oligosaccharide for increasing probiotic activity |
AP Technologies | Filed | 2018 -09-12 |
10201 4925 |
| Composition for synbiotics,probiotic width human milk oligosaccharide | AP Technologies | Filed | 2019 -04-22 |
10197 2925 |
| Patent name | Applicant | Application/ Registration |
Date of resistration | Registration number |
|---|---|---|---|---|
| Process for preparation of polypeptides of interest from fusion polypeptides | AP Technologies | Approved | 2005 -12-02 |
10053 5265 |
| Method for preparation of nanostructured complex if hydrophobic drug | AP Technologies Sungkyunkwan University Industry-Unibersity cooperation foundation |
Approved | 2012 -03-21 |
10113 1202 |
| Thrombopoientin developed with mass production for oral dosage and mass production process thereof |
AP Technologies | Approved | 2017 -12-26 |
10181 4048 |
| Antibody binding affinity ligan with advaned alkali resistance | AP Technologies | Approved | 2019 -06-21 |
10199 3845 |
| New ketol-acid reductoisomerase with a cofactor preference to NADH developed | AP Technologies Korea University Industry-Unibersity cooperation foundation |
Approved | 2019 -03-14 |
10196 0501 |
| PROCESS FOR PURIFICATION OF RECOMBINANT ADENOVIRUS TYPE 3 FIBER POLYPEPTIDE | AP Technologies Samayng Bio Pharm Co.,Ltd |
Approved | 2018 -10-02 |
10190 6319 |
| A recombinate organism enhancend furfural tolerance and method for production of isobytanol using the same |
AP Technologies Konkuk University Industry-Unibersity cooperation foundation |
Approved | 2018 -08-02 |
10188 6186 |
| Method for isolation of L-arabinose by arabinofuranosidase treatment with addition of KCI or NaCI |
AP Technologies Chungbuk National University Industry-Unibersity cooperation foundation |
Approved | 2010 -09-14 |
10098 3324 |
이메일 무단수집을 거부합니다.
본 웹사이트에 게시된 이메일 주소가 전자우편 수집 프로그램이나 그 밖의 기술적 장치를 이용하여 무단으로 수집되는 것을 거부하며, 이를 위반시 정보통신망법에 의해 형사 처벌됨을 유념하시기 바랍니다.
ENG